Dynamic competition in pharmaceuticals: Patent expiry, generic penetration, and industry structure

European Journal of Health Economics

Volumn 5, Issue 2, 2004, Pages 175-182

  Magazzini, Laura ^a   Pammolli, Fabio ^b,c   Riccaboni, Massimo ^b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b CERM   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Patent expiration; Pharmaceuticals

Indexed keywords

GENERIC DRUG;

ARTICLE; COMPETITION; DRUG INDUSTRY; ECONOMIC ASPECT; FRANCE; GERMANY; HEALTH CARE POLICY; PATENT; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES;

COSTS AND COST ANALYSIS; DRUG INDUSTRY; DRUGS, GENERIC; ECONOMIC COMPETITION; FRANCE; GERMANY; GREAT BRITAIN; MODELS, ECONOMIC; PATENTS; UNITED STATES;

EID: 3042677393     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ahn S (2002) Competition, innovation, and productivity growth: a review of theory and evidence. OECD Economics Department, Working Paper 317
2. Ashiya M (2000) Weak entrants are welcome. Int J Ind Organi 18:975-984
3. Bae JP (1997) Drug patent expirations and the speed of generic entry. Health Serv Res 32:187-101
4. Blundell R, Griffith R, Van Reenen J (1995) Dynamic count data models of technological innovation. Econ J 105:333-344
5. Caves RE, Whinston MD, Hurwitz MA (1991) Patent expiration, entry and competition in the US pharmaceutical industry. Brookings Papers on Economic Activity. Microeconomics 1991:1-48
6. Ching ATT (2000) Dynamic equilibrium in the prescription drug market after patent expiration. PhD Dissertation, University of Minnesota
7. Cohen W, Levin R (1989) Empirical studies of innovation and market structure. In: R Schmalensee, J Willing (eds). The handbook of industrial organization, I. North Holland, Amsterdam, pp 1059-1107
8. Danzon PM, Chao LW (2000) Cross-national price differences for pharmaceuticals: how large and why? J Health Econ 19:159-195
9. Eswaran M (1994) Licensees as entry barriers. Can J Econ 27:673-688
10. Gambardella A, Orsenigo L, Pammolli F (2001) Global competitiveness in pharmaceuticals. A European perspective. Directorate General Enterprise, European Commission, Brussels
11. Garattini L, Tediosi F (2000) A comparative analysis of generics markets in five European countries. Health Pol 51:149-162
12. Grabowski HG, Vernon JM (1992) Brand loyalty, entry and price competition in the pharmaceuticals after the 1984 Drug Act. J Law Econ 35:331-350
13. Grabowski HG, Vernon JM (1996) Longer patents for increased generic competition in the US. Pharmacoeconomics 10:110-123
14. Hollis A (2003) The anti-competitive effects of brand-controlled 'Pseudo-Generics' in the Canadian pharmaceutical market. Can Public Policy 29:21-31
15. Hudson J (2000) Generic take-up in the pharmaceutical market following patent expiry. A multi-country study. Int Rev Law Econ 20:205-221
16. Hurwitz MA, Caves RE (1988) Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. J Law Econ 31:299-320
17. Jacobzone S (2000) Pharmaceutical policies in OECD countries: reconciling social and industrial goals. OECD Labor Market and Social Policy Occasional Papers, 40
18. López-Casanovas G, Jönsson B (2001) Reference pricing and pharmaceutical policy: perspectives on economics and innovation. Kluwer, Dordrecht
19. Pammolli F, Magazzini L, Orsenigo L, (2002) The intensity of competition after patent expiry in pharmaceuticals: a cross-country analysis. Rev Econ Ind 99:107-132
20. Mossialos E (1997) Citizens' view on health systems in the 15 member states of the European Union. Health Econ 6:109-116
21. NERA (1998) Policy relating to generic medicines in the OECD. Report for the European Commission, Brussels
22. Scott Morton FM (1997) Entry decision in the generic pharmaceutical industry. NBER Working Paper 6190
23. Suh DC (1993) Effect of multiple source entry on price competition after patent expiration in the pharmaceutical industry. PhD Dissertation, University of Minnesota
24. Yi S (1999) Entry, licensing and research joint ventures. Int J Ind Organi 17:1-24